Quva pharma, INC.:1327585 [pots: 20-011327]

Ended Awarded Last action

Contract number
75N90020F00002
Awardee
Awarding agency
Obligated
$174,000

Award facts

Contract value 100% obligated
$174,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Sugar Land, TX 77478, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 · Quva pharma, INC.:1327585 [pots: 21-007858] $140,000
Exercise an Option P00001 $28,000
Original award $6,000

About this award

Quva Pharma, Inc. was awarded a $174,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Health and Human Services' National Institutes of Health Clinical Center. The delivery order, number 1327585 under request for proposal number 20-011327, calls for Quva Pharma to provide unspecified products or services to the NIH Clinical Center in Sugar Land, Texas, with work to be completed by March 31, 2022. No set-aside designation was applied to this award.

Quick answers

Who was awarded contract 75N90020F00002?

75N90020F00002 was awarded to Quva Pharma, Inc. by NIH Clinical Center (National Institutes of Health) on September 27, 2020.

How much is contract 75N90020F00002 worth?

The government has obligated $174,000 on 75N90020F00002.

Is contract 75N90020F00002 an order under another contract?

Yes. 75N90020F00002 is a delivery order under 75N90019D00030, an indefinite delivery contract.

Was contract 75N90020F00002 competed?

The extent of competition for 75N90020F00002 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award